Patent Assignment
Reel/Frame 047107/0116
Security Interest
Recorded: 2018-10-09
Pages: 12
Assignor
IMMUNE PHARMACEUTICALS INC.
Executed: 2018-10-09
Assignee
DISCOVER GROWTH FUND, LLC
5330 YACHT HAVEN GRANDE, SUITE 206, ST. THOMAS, VIRGIN ISLANDS, U.S., 00802
Covered Properties
(20)
Dipeptide Caspase Inhibitors and the Use Thereof
Patent:
6,153,591 →
Application:
09/270,735 →
Dipeptide Apoptosis Inhibitors and the Use Thereof
Patent:
6,184,210 →
Application:
09/270,736 →
Ketamine and N-Butyl-P-Aminobezoate in Plo
Patent:
6,017,961 →
Application:
09/350,062 →
Novel fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof
Patent:
6,335,429 →
Application:
09/521,650 →
Human Antibodies Against Eotaxin.
Topical Compositions and Methods for Treating Pain
Use of Anti-Ferritin Monoclonal Antibodies in the Treatment of Some Cancers
7,8-Fused 4H-Chromene and Analogs as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
Patent:
6,858,607 →
Application:
10/146,139 →
4-Substituted-1- (Arylmethylidene) Thiosemicarbazide, 4-Substituted-1- (Arylcarbonyl) Thiosemicarbazide and Analogs as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
Methods and Compositions for Treating Pain of the Mucous Membrane
Methods of Obtaining a Specific Binding Member That Binds Eotaxin
4-Arylamino-Quinazolines and Analogs as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
Method of Treating Brain Cancer
Substituted 4-Aryl-Chromene as Activator of Caspases and Inducer of Apoptosis and as Antivascular Agent and the Use Thereof
Methods of Obtaining a Specific Binding Member That Binds Eotaxin
Methods of Obtaining a Specific Binding Member That Binds Eotaxin
Use of Anti-Eotaxin Antibodies for Treating Inflammatory Bowel Disease
Application:
13/864,387 →
Publication:
US 2014/0271666
Methods of Obtaining a Specific Binding Member That Binds Eotaxin
Human Antibodies Against Eotaxin and Their Use
Use of Anti-Eotaxin Antibodies for Treating Inflammatory Bowel Disease
Application:
15/347,847 →
Publication:
US 2017/0247442
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 24, 2000
From: CAI, SUI XIONG; DREWE, JOHN; WANG, YAN; WEBER, ECKARD
To: CYTOVIA, INC.
Reel/Frame 011078/0189 →
Assignment of Assignor's Interest
Dec 21, 2001
From: WILLIAMS, ROBERT O.; ZHANG, FENG
To: EPICEPT CORPORATION
Reel/Frame 012388/0731 →
Assignment of Assignor's Interest
Feb 15, 2002
From: KADOUCHE, JEAN; LEVY, RAFAEL
To: MONOCLONAL ANTIBODIES THERAPEUTICS "M.A.T."
Reel/Frame 012623/0952 →
Assignment of Assignor's Interest
Sep 6, 2002
From: CAI, SUI XIONG; NGUYEN, BAO NGOC; DREWE, JOHN; REDDY, P. SANJEEVA
To: CYTOVIA, INC.
Reel/Frame 013268/0233 →
Assignment of Assignor's Interest
Oct 4, 2002
From: CAI, SUI XIONG; XU, LIFEN; STORER, RICHARD; ATTARDO, GIORGIO
To: CYTOVIA, INC.
Reel/Frame 013359/0387 →
Assignment of Assignor's Interest
Jun 27, 2003
From: VAUGHAN, TRISTAN JOHN; WILTON, ALISON JANE; SMITH, STEPHEN; MAIN, SARAH HELEN
To: CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
Reel/Frame 013765/0019 →
Assignment of Assignor's Interest
Jun 27, 2003
From: VAUGHAN, TRISTAN JOHN; WILTON, ALISON LANE; SMITH, STEPHEN; MAIN, SARAH HELEN
To: CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
Reel/Frame 013765/0026 →
Security Agreement
Jan 20, 2004
From: AMERIFAB ACQUISITION CORP.
To: NATIONAL CITY BANK OF INDIANA
Reel/Frame 014268/0321 →
Assignment of Assignor's Interest
Sep 20, 2004
From: CAI, SUI XIONG; SIRISOMA, NILANTHA SUDATH; PERVIN, AZRA; DREWE, JOHN A.
To: CYTOVIA, INC.
Reel/Frame 015152/0032 →
Assignment of Assignor's Interest
Sep 20, 2004
From: PLEIMAN, CHRIS; BAICHWAL, VIJAY; MANFREDI, JOHN; BHOITE, LEENA
To: MYRIAD GENETICS, INC.
Reel/Frame 015151/0933 →
Corrective Assignment to Correct the Schedule B of the Security Agreement Incorrectly Lists Us Pat No. 6,509,028 Previously Recorded on Reel 014268 Frame 0321. Assignor(S) Hereby Confirms the Security Agreement Should Have Given a Security Interest in Us Pat No. 6,059,028.
Aug 23, 2005
From: NATIONAL CITY BANK OF INDIANA
To: EPICEPT CORPORATION
Reel/Frame 016438/0142 →
Assignment of Assignor's Interest
Jan 18, 2006
From: PHILLIPS, ROB L.
To: CROWLEY, KENTON L.; FLORES, JOHN A
Reel/Frame 017198/0558 →
Assignment of Assignor's Interest
Jan 18, 2006
From: CROWLEY, KENTON L.; FLORES, JOHN A.
To: EPICEPT CORPORATION
Reel/Frame 017198/0548 →
Assignment of Assignor's Interest
Oct 2, 2007
From: CAI, SUI XIONG; DREWE, JOHN A.; KASIBHATLA, SHAILAJA; KEMNITZER, WILLIAM E.
To: CYTOVIA, INC.
Reel/Frame 019906/0041 →
Assignment of Assignor's Interest
Oct 4, 2007
From: CAI, SUI-XIONG; SIRISOMA, NILANTHA SUDATH
To: CYTOVIA, INC.
Reel/Frame 019922/0630 →
Assignment of Assignor's Interest
Oct 4, 2007
From: ANDERSON, MARK B.; WILLARDSEN, ADAM
To: MYRIAD GENETICS, INC.
Reel/Frame 019922/0573 →
Assignment of Assignor's Interest
Aug 6, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023061/0882 →
Assignment of Assignor's Interest
Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023136/0158 →
Assignment of Assignor's Interest
Sep 2, 2009
From: PASTERNAK, GAVRIL W.; KOLESNIKOV, YURI A.
To: MEMORIAL SLOAN-KETTERING CANCER CENTER
Reel/Frame 023184/0511 →
Change of Name
Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024855/0508 →
Change of Name
Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024852/0481 →
Security Agreement
May 31, 2011
From: EPICEPT CORPORATION; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
To: MIDCAP FUNDING III, LLC
Reel/Frame 026360/0023 →
Change of Name
Sep 26, 2011
From: CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
To: MEDIMMUNE LIMITED
Reel/Frame 026968/0849 →
Change of Name
Oct 14, 2011
From: CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
To: MEDIMMUNE LIMITED
Reel/Frame 027066/0667 →
Assignment of Assignor's Interest
Jul 8, 2013
From: TEPER, DANIEL
To: IMMUNE PHARMACEUTICALS LTD.
Reel/Frame 030748/0348 →